Clinical Trials Sponsored by Diana Lee Farmer
Total 1210 results
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedEarly-Stage Breast CancerUnited States
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer Network; AVEO Pharmaceuticals, Inc.TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Medical CenterCompleted
-
Cellceutix CorporationDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedSolid TumorsUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Boston Children's HospitalCompletedSarcoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Neuroblastoma | Central Nervous System Tumor, PediatricUnited States
-
Piramal Enterprises LimitedDana-Farber Cancer Institute; Norris Cotton Cancer CenterSuspendedRelapsed/Refractory Chronic Lymphocytic Leukemia (CLL)United States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedStomach Cancer | Gastric Cancer | Gastro-esophageal Junction CancerUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Brigham and Women's HospitalTerminatedChronic Graft-versus-host DiseaseUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
Jiping Wang, MD, PhDAstraZeneca; Sirtex MedicalRecruitingHepatocellular Carcinoma | Hepatocellular Cancer | Resectable Hepatocellular CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Philips HealthcareCompletedLung; Node | Peripheral Pulmonary Nodules | Cone Beam Computed Tomography | Guided Navigation BronchoscopyUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer InstituteActive, not recruitingAstrocytoma | Brain Tumor | Ependymoma | Ganglioglioma | Low Grade GliomaUnited States
-
Adrienne G. WaksMerck Sharp & Dohme LLCActive, not recruiting
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Prevent Cancer FoundationCompletedEnvironmental Exposure to Ultraviolet LightUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedVenous ThormboembolismUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States
-
Beth Israel Deaconess Medical CenterGE HealthcareTerminated
-
Dana-Farber Cancer InstitutePatty Brisben Foundation For Women's Sexual HealthCompletedOvarian CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Akorn, Inc.Withdrawn
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Roche Pharma AGCompleted
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Rhone-Poulenc RorerCompletedProstate CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Celgene; Schering-PloughCompletedBrain and Central Nervous System TumorsUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); AstraZeneca; MedImmune LLCCompletedHead and Neck Cancer | Mucositis | Xerostomia | Radiation Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Novartis PharmaceuticalsCompleted
-
Steven P. Treon, MD, PhDCelgene CorporationTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteBoston Children's Hospital; Brigham and Women's HospitalCompletedMyelogenous Leukemia, AcuteUnited States
-
Dana-Farber/Brigham and Women's Cancer CenterNational Cancer Institute (NCI)UnknownPrecancerous ConditionUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Completed
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedOvarian Cancer | Peritoneal Carcinoma | Tubal CarcinomaUnited States
-
Sigma-Tau Research, Inc.Dana-Farber Cancer Institute; Rhode Island HospitalCompletedSolid MalignanciesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedAdenocarcinoma of Stomach | Adenocarcinoma of GE Junction | Adenocarcinoma of EsophagusUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNon-Small Cell Lung CancerUnited States
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Dana-Farber Cancer InstitutePfizer; Prostate Cancer Foundation; Myovant Sciences GmbHRecruitingProstatic Neoplasms | Prostate CancerUnited States
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruitingSmoking Cessation | Lung CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States